This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

The Platform for Interdisciplinary Cardiovascular-metabolic-neurovascular Diseases (PICMAN)

Sponsored by National University Hospital, Singapore

About this trial

Last updated 2 years ago

Study ID

PICMAN

Status

Recruiting

Type

Observational [Patient Registry]

Placebo

No

Accepting

18-75 Years
21 to 70 Years
All
All

Trial Timing

Ended a year ago

What is this trial about?

Background Changes in metabolism and mitochondrial function appear to precede cardiac dysfunction, with much evidence supporting metabolic dysregulation as one of the earliest precursors of cardiovascular disease. We hypothesise that quantifiable metabolic inflexibility may be representative of an individual in his/her silent, but high-risk progression towards insulin resistance, diabetes and cardiovascular disease. The platform for interdisciplinary cardiovascular-metabolic-neurovascular diseases (PICMAN) across National University Health System (NUHS) is a pilot, prospective, multi-ethnic cohort study in Singapore. Through extensive phenotyping in a preventive cardiology cohort, the central aim is to define the metabolic flexibility range in a cohort of individuals at elevated risk of atherosclerotic cardiovascular disease, to correlate metabolic flexibility to measures of cardiometabolic health, including diastolic dysfunction, coronary and cerebral atherosclerosis, body fat distribution and severity of non-alcoholic fatty liver disease.

What are the participation requirements?

Yes

Inclusion Criteria

- Patients aged 21-70 at screening

- 10-year ASCVD risk > 5% measured by QRISK 3 calculator

No

Exclusion Criteria

- Established DM (Prior diagnosis, long term medications or HbA1c >=6.5)

- Established CVD, such as ischemic heart disease, cerebrovascular accident, heart failure, atrial fibrillation

- Pregnancy

- Known contraindications to CT scan, such as allergy to contrast

Locations

Location

Status

Recruiting